Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7
Clinical trial NCT02601014 · COMPLETED
Trial details
- NCT number
- NCT02601014
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-15
- Primary completion
- 2020-12-03
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.